Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATOM2: Atropine for the Treatment of Childhood Myopia
NCT00371124Phase 3Unknown
- Sponsor
- Singapore National Eye Centre
- Start
- Mar 2006
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of NVK002 in myopia, sponsored by Singapore National Eye Centre. Status: unknown.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT00371124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371124.